loading page

Transcatheter Aortic Valve Implantation (TAVI): Is General Anaesthesia a Necessity?
  • Sugeevan Savarimuthu,
  • Amer Harky
Sugeevan Savarimuthu
Broomfield Hospital
Author Profile
Amer Harky
Liverpool Heart and Chest Hospital NHS Foundation Trust
Author Profile

Abstract

Transcatheter Aortic Valve Implantation (TAVI) has emerged over the last decade and has become a viable treatment option for those with severe symptomatic aortic stenosis (AS). The numbers of TAVI that are being performed in centres across the world is rising rapidly, and revolutionising treatment for AS and steering away from the need for open heart surgery. TAVI has been targeted for those who are deemed high risk to undergo open heart surgery such as the elderly, frail, or those with multiple co-morbidities. General anaesthesia (GA) has been used to facilitate TAVI especially when the procedure was in its infancy. The use of GA comes with its own set of risks such as haemodynamic compromise, risk for aspiration, longer procedure time and post-operative nausea and vomiting. These side effects and or complications may not be tolerated well in those who are elderly or have numerous co-morbidities. This article seeks to understand the outcomes of patients who undergo TAVI with the support of sedation and local anaesthesia (LA) in comparison to those who received GA.

Peer review status:UNDER REVIEW

22 Jul 2021Submitted to Journal of Cardiac Surgery
23 Jul 2021Assigned to Editor
23 Jul 2021Submission Checks Completed
26 Jul 2021Reviewer(s) Assigned